Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00712140 |
Recruitment Status : Unknown
Verified November 2008 by National Cancer Institute (NCI).
Recruitment status was: Recruiting
First Posted : July 9, 2008
Last Update Posted : September 2, 2011
|
Sponsor:
Warwick Medical School
Information provided by:
National Cancer Institute (NCI)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | October 2011 |
Study Completion Date : | No date given |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):